JP2023502398A5 - - Google Patents
Info
- Publication number
- JP2023502398A5 JP2023502398A5 JP2022529066A JP2022529066A JP2023502398A5 JP 2023502398 A5 JP2023502398 A5 JP 2023502398A5 JP 2022529066 A JP2022529066 A JP 2022529066A JP 2022529066 A JP2022529066 A JP 2022529066A JP 2023502398 A5 JP2023502398 A5 JP 2023502398A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962937395P | 2019-11-19 | 2019-11-19 | |
| US62/937,395 | 2019-11-19 | ||
| PCT/US2020/061028 WO2021101975A1 (en) | 2019-11-19 | 2020-11-18 | Methods of treating warm autoimmune hemolytic anemia using anti-fcrn antibodies |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023502398A JP2023502398A (ja) | 2023-01-24 |
| JP2023502398A5 true JP2023502398A5 (https=) | 2023-11-15 |
| JPWO2021101975A5 JPWO2021101975A5 (https=) | 2023-11-15 |
| JP7722991B2 JP7722991B2 (ja) | 2025-08-13 |
Family
ID=73854886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529066A Active JP7722991B2 (ja) | 2019-11-19 | 2020-11-18 | 抗ｆｃｒｎ抗体を用いた温熱自己免疫性溶血性貧血の治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230049011A1 (https=) |
| EP (1) | EP4061486A1 (https=) |
| JP (1) | JP7722991B2 (https=) |
| KR (1) | KR20220100880A (https=) |
| CN (1) | CN114728180A (https=) |
| AU (1) | AU2020387399A1 (https=) |
| CA (1) | CA3157797A1 (https=) |
| IL (1) | IL292889A (https=) |
| MX (1) | MX2022005862A (https=) |
| TW (1) | TW202132346A (https=) |
| WO (1) | WO2021101975A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250136699A1 (en) * | 2021-08-13 | 2025-05-01 | Jiangsu Biojetay Biotechnology Co., Ltd. | Antibodies specifically recognizing fcrn and uses thereof |
| AU2023281650A1 (en) | 2022-05-30 | 2024-10-17 | Hanall Biopharma Co., Ltd. | Anti-fcrn antibody or antigen binding fragment thereof with improved stability |
| US20260078188A1 (en) * | 2022-09-06 | 2026-03-19 | Immunovant Sciences Gmbh | Methods of treating graves’ disease using anti-fcrn antibodies |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3137504T3 (fi) | 2014-04-30 | 2023-08-07 | Hanall Biopharma Co Ltd | Fcrn:ään sitoutuva vasta-aine autoimmuunisairauksien hoitamista varten |
| US10336825B2 (en) * | 2014-04-30 | 2019-07-02 | Hanall Biopharma Co., Ltd. | Antibody binding to FcRn for treating autoimmune diseases |
| KR20250052465A (ko) * | 2015-01-30 | 2025-04-18 | 모멘타 파머슈티컬스 인코포레이티드 | ＦｃＲｎ 항체 및 이의 사용 방법 |
| ES2956662T3 (es) * | 2015-05-12 | 2023-12-26 | Syntimmune Inc | Anticuerpos anti-FcRn humanizados con afinidad madurada |
| CA3032415A1 (en) * | 2016-07-29 | 2018-02-01 | Momenta Pharmaceuticals, Inc. | Fcrn antibodies and methods of use thereof |
| WO2019160979A1 (en) * | 2018-02-13 | 2019-08-22 | The Brigham And Women's Hospital, Inc. | Therapeutic fcrn-based bispecific monoclonal antibodies |
-
2020
- 2020-11-18 US US17/777,913 patent/US20230049011A1/en active Pending
- 2020-11-18 CA CA3157797A patent/CA3157797A1/en active Pending
- 2020-11-18 IL IL292889A patent/IL292889A/en unknown
- 2020-11-18 WO PCT/US2020/061028 patent/WO2021101975A1/en not_active Ceased
- 2020-11-18 EP EP20825291.6A patent/EP4061486A1/en active Pending
- 2020-11-18 JP JP2022529066A patent/JP7722991B2/ja active Active
- 2020-11-18 MX MX2022005862A patent/MX2022005862A/es unknown
- 2020-11-18 CN CN202080080573.3A patent/CN114728180A/zh active Pending
- 2020-11-18 TW TW109140405A patent/TW202132346A/zh unknown
- 2020-11-18 KR KR1020227016333A patent/KR20220100880A/ko active Pending
- 2020-11-18 AU AU2020387399A patent/AU2020387399A1/en not_active Abandoned